PREPARATION AND BIODISTRIBUTION OF ~(188)Re-TCTMP
Jiang Shu
Abstract
Jiang Shu
Abstract
TCTMP(1,4,8,11tertraaza cyclotetradecyl1,4,8,11tetramethylene phosphonate) is synthesized and coupled with 188Re. The coupling condition,stability and biodistribution of 188ReTCTMP in mice are investigated. The results show that satisfactory complexation yield of 188Re could be obtained under condition of medium pH=2.0,0.8~1.6 mg of SnCl2 and 50 mg of ligand. The complex exhibits high stability and maintains its high complexation yield (95%) in 8 d without protection of N2. The results of biodistribution indicate considerably strong affinity of 188ReTCTMP to bone and very low nontarget tissue's uptake. The concentration of 188ReTCTMP in blood is (0.06±0.02)%/g at 6 h after injection,while the concentration of 188ReHEDP is (0.28±0.05) %/g at 6 h after injection,which might be due to the higher stability of 188ReTCTMP in vitro and in vivo. Comparing with 188ReHEDP,188ReTCTMP exhibits better potential for the treatment of metastases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
TCTMP(1,4,8,11tertraaza cyclotetradecyl1,4,8,11tetramethylene phosphonate) is synthesized and coupled with 188Re. The coupling condition,stability and biodistribution of 188ReTCTMP in mice are investigated. The results show that satisfactory complexation yield of 188Re could be obtained under condition of medium pH=2.0,0.8~1.6 mg of SnCl2 and 50 mg of ligand. The complex exhibits high stability and maintains its high complexation yield (95%) in 8 d without protection of N2. The results of biodistribution indicate considerably strong affinity of 188ReTCTMP to bone and very low nontarget tissue's uptake. The concentration of 188ReTCTMP in blood is (0.06±0.02)%/g at 6 h after injection,while the concentration of 188ReHEDP is (0.28±0.05) %/g at 6 h after injection,which might be due to the higher stability of 188ReTCTMP in vitro and in vivo. Comparing with 188ReHEDP,188ReTCTMP exhibits better potential for the treatment of metastases.
Key concepts: Biodistribution, Chemistry, Yield (engineering), Phosphonate, Ligand (biochemistry), In vivo, Nuclear chemistry, In vitro